NOVOSENSE (02676) announced its allotment results, with a global offering of 19.0684 million shares. The Hong Kong public offering accounted for 10% of the total, while the international offering made up the remaining 90%. The issue price was set at HK$116 per share, raising approximately HK$2.0964 billion in net proceeds. Each board lot consists of 100 shares, and the H-shares are expected to commence trading on the Hong Kong Stock Exchange at 9:00 a.m. on Monday, December 8, 2025. The Hong Kong public offering was oversubscribed by 25.33 times, and the international offering was oversubscribed by 2.65 times.